• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤代谢作为 B 细胞淋巴瘤微环境中肿瘤-宿主相互作用的调节剂——促进进展和新的治疗靶点。

Tumor Metabolism as a Regulator of Tumor-Host Interactions in the B-Cell Lymphoma Microenvironment-Fueling Progression and Novel Brakes for Therapy.

机构信息

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Josef Stelzmann Street 24, 50937 Cologne, Germany.

出版信息

Int J Mol Sci. 2019 Aug 26;20(17):4158. doi: 10.3390/ijms20174158.

DOI:10.3390/ijms20174158
PMID:31454887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6747254/
Abstract

Tumor metabolism and its specific alterations have become an integral part of understanding functional alterations leading to malignant transformation and maintaining cancer progression. Here, we review the metabolic changes in B-cell neoplasia, focusing on the effects of tumor metabolism on the tumor microenvironment (TME). Particularly, innate and adaptive immune responses are regulated by metabolites in the TME such as lactate. With steadily increasing therapeutic options implicating or utilizing the TME, it has become essential to address the metabolic alterations in B-cell malignancy for therapeutic approaches. In this review, we discuss metabolic alterations of B-cell lymphoma, consequences for currently used therapy regimens, and novel approaches specifically targeting metabolism in the TME.

摘要

肿瘤代谢及其特定改变已成为理解导致恶性转化和维持癌症进展的功能改变的一个组成部分。在这里,我们回顾了 B 细胞肿瘤发生中的代谢变化,重点讨论了肿瘤代谢对肿瘤微环境(TME)的影响。特别是,TME 中的代谢物,如乳酸盐,调节先天和适应性免疫反应。随着越来越多的治疗选择涉及或利用 TME,解决 B 细胞恶性肿瘤中的代谢改变对于治疗方法变得至关重要。在这篇综述中,我们讨论了 B 细胞淋巴瘤的代谢改变、对当前治疗方案的影响以及专门针对 TME 代谢的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb56/6747254/b45dfde2afa8/ijms-20-04158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb56/6747254/b45dfde2afa8/ijms-20-04158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb56/6747254/b45dfde2afa8/ijms-20-04158-g001.jpg

相似文献

1
Tumor Metabolism as a Regulator of Tumor-Host Interactions in the B-Cell Lymphoma Microenvironment-Fueling Progression and Novel Brakes for Therapy.肿瘤代谢作为 B 细胞淋巴瘤微环境中肿瘤-宿主相互作用的调节剂——促进进展和新的治疗靶点。
Int J Mol Sci. 2019 Aug 26;20(17):4158. doi: 10.3390/ijms20174158.
2
Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities.靶向 B 细胞淋巴瘤的肿瘤微环境:挑战与机遇。
J Hematol Oncol. 2021 Aug 17;14(1):125. doi: 10.1186/s13045-021-01134-x.
3
The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitors.淋巴瘤的肿瘤微环境:检查点抑制剂的潜在作用和作用方式的深入了解。
Hematol Oncol. 2021 Feb;39(1):3-10. doi: 10.1002/hon.2821. Epub 2020 Nov 6.
4
β-Adrenergic Signaling Impairs Antitumor CD8 T-cell Responses to B-cell Lymphoma Immunotherapy.β-肾上腺素能信号会损害抗肿瘤 CD8 T 细胞对 B 细胞淋巴瘤免疫治疗的反应。
Cancer Immunol Res. 2018 Jan;6(1):98-109. doi: 10.1158/2326-6066.CIR-17-0401. Epub 2017 Nov 16.
5
Microenvironment signaling driving lymphomagenesis.微环境信号驱动淋巴瘤发生。
Curr Opin Hematol. 2018 Jul;25(4):335-345. doi: 10.1097/MOH.0000000000000440.
6
cROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies.跨越界限:B 细胞恶性肿瘤中活性氧物种有益与有害效应之间。
Front Immunol. 2020 Jul 21;11:1538. doi: 10.3389/fimmu.2020.01538. eCollection 2020.
7
Lactate in the tumour microenvironment: From immune modulation to therapy.肿瘤微环境中的乳酸:从免疫调节到治疗。
EBioMedicine. 2021 Nov;73:103627. doi: 10.1016/j.ebiom.2021.103627. Epub 2021 Oct 14.
8
Targeting the Tumor Microenvironment of Leukemia and Lymphoma.靶向白血病和淋巴瘤的肿瘤微环境
Trends Cancer. 2019 Jun;5(6):351-364. doi: 10.1016/j.trecan.2019.05.001. Epub 2019 Jun 5.
9
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.通过联合靶向血管生成和PD-1/PD-L1通路增强抗癌免疫力:挑战与机遇
Front Immunol. 2020 Nov 5;11:598877. doi: 10.3389/fimmu.2020.598877. eCollection 2020.
10
A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity.CAR T 细胞亚群与肿瘤微环境之间的串扰对于持续的细胞毒性活性至关重要。
Sci Immunol. 2021 Mar 26;6(57). doi: 10.1126/sciimmunol.abd4344.

引用本文的文献

1
Development and validation of prognostic nomogram for overall survival in canine multicentric lymphoma: a retrospective study.犬多中心淋巴瘤总生存预后列线图的开发与验证:一项回顾性研究
BMC Vet Res. 2025 Jul 2;21(1):433. doi: 10.1186/s12917-025-04857-y.
2
Macrophages are activated toward phagocytic lymphoma cell clearance by pentose phosphate pathway inhibition.巨噬细胞通过磷酸戊糖途径抑制被激活以清除吞噬性淋巴瘤细胞。
Cell Rep Med. 2024 Dec 17;5(12):101830. doi: 10.1016/j.xcrm.2024.101830. Epub 2024 Nov 26.
3
The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma.

本文引用的文献

1
Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells.伊马替尼调控 BCR-ABL 驱动的慢性髓系白血病细胞糖酵解酶和 OXPHOS 的协同作用。
Int J Mol Sci. 2019 Jun 27;20(13):3134. doi: 10.3390/ijms20133134.
2
Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II.半胱氨酸耗竭通过抑制电子传递复合物 II 靶向白血病干细胞。
Blood. 2019 Jul 25;134(4):389-394. doi: 10.1182/blood.2019898114. Epub 2019 May 17.
3
The multifaceted effects of metformin on tumor microenvironment.
弥漫性大B细胞淋巴瘤中的代谢与免疫环境
Metabolites. 2023 Jun 8;13(6):734. doi: 10.3390/metabo13060734.
4
Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin's Lymphoma.代谢组学:B细胞非霍奇金淋巴瘤诊断或预后的新时代。
Diagnostics (Basel). 2023 Feb 23;13(5):861. doi: 10.3390/diagnostics13050861.
5
Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next?治疗B细胞恶性肿瘤新型药物的现状:接下来会有什么进展?
Cancers (Basel). 2022 Dec 7;14(24):6026. doi: 10.3390/cancers14246026.
6
Scaffold-mediated switching of lymphoma metabolism in culture.支架介导的培养中淋巴瘤代谢转换
Cancer Metab. 2022 Oct 12;10(1):15. doi: 10.1186/s40170-022-00291-y.
7
PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients.PI3Kδ抑制剂作为治疗淋巴瘤患者的免疫调节剂
Cancers (Basel). 2021 Nov 4;13(21):5535. doi: 10.3390/cancers13215535.
8
A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors.一组在大脑和脑脊液中都存在的 17 种 microRNAs 可将原发性中枢神经系统淋巴瘤与非恶性脑肿瘤区分开来。
Biomolecules. 2021 Sep 21;11(9):1395. doi: 10.3390/biom11091395.
9
Knockdown of Chitinase 3-Like-1 Inhibits Cell Proliferation, Promotes Apoptosis, and Enhances Effect of Anti-Programmed Death Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma Cells.敲低几丁质酶 3 样蛋白 1 抑制弥漫大 B 细胞淋巴瘤细胞增殖,促进细胞凋亡,并增强抗程序性死亡配体 1(PD-L1)的效果。
Med Sci Monit. 2021 Mar 25;27:e929431. doi: 10.12659/MSM.929431.
10
The Importance of Tumor-Host Interactions in Adult B-Cell Leukemias and Lymphomas.肿瘤宿主相互作用在成人 B 细胞白血病和淋巴瘤中的重要性。
Int J Mol Sci. 2020 Sep 21;21(18):6915. doi: 10.3390/ijms21186915.
二甲双胍对肿瘤微环境的多方面影响。
Semin Cell Dev Biol. 2020 Feb;98:90-97. doi: 10.1016/j.semcdb.2019.05.010. Epub 2019 May 22.
4
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8 T cells and impede CAR T-cell efficacy.慢性淋巴细胞白血病细胞损害 CD8 T 细胞中的线粒体功能,从而阻碍嵌合抗原受体 T 细胞疗法的疗效。
Blood. 2019 Jul 4;134(1):44-58. doi: 10.1182/blood.2018885863. Epub 2019 May 10.
5
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma.向氧化磷酸化代谢重编程鉴定出治疗套细胞淋巴瘤的一个治疗靶点。
Sci Transl Med. 2019 May 8;11(491). doi: 10.1126/scitranslmed.aau1167.
6
Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents.高剂量烷化剂诱导淋巴瘤清除的机制。
Cancer Discov. 2019 Jul;9(7):944-961. doi: 10.1158/2159-8290.CD-18-1393. Epub 2019 Apr 30.
7
Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.培门冬酶:急性淋巴细胞白血病治疗中的应用评价。
Drugs. 2019 May;79(7):767-777. doi: 10.1007/s40265-019-01120-1.
8
CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages.CSF1R 和 BTK 抑制作为破坏套细胞淋巴瘤和巨噬细胞之间对话的新策略。
Leukemia. 2019 Oct;33(10):2442-2453. doi: 10.1038/s41375-019-0463-3. Epub 2019 Apr 2.
9
Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.代谢相关生物标志物在非霍奇金淋巴瘤中的临床意义——MCT1 作为弥漫性大 B 细胞淋巴瘤的潜在靶点。
Cell Oncol (Dordr). 2019 Jun;42(3):303-318. doi: 10.1007/s13402-019-00426-2. Epub 2019 Feb 21.
10
Immune control by amino acid catabolism during tumorigenesis and therapy.肿瘤发生和治疗过程中氨基酸分解代谢的免疫控制。
Nat Rev Cancer. 2019 Mar;19(3):162-175. doi: 10.1038/s41568-019-0106-z.